Kibaran walked away from Ndololo, for what it's worth, in pursuit of superior, nearby deposits. Look at them now, On the way waaayyyy up. That said, may be worth chucking a small investment into GRK, could multiply by multiple orders of magnitude.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025